A novel process of creating a cannabinoid pico-emulsion resulting in a sterile and injectable cannabinoid emulsion with increased bioavailability and antibiotic characteristics, and the resulting novel cannabinoid pico-emulsion, for the purpose of treating a wide variety of medical condition in both human and animals.

Compositions and Methods A method of producing a medicinal composition comprising an extract of cannabis plant material comprises: (i) mixing, for example dissolving, an extract of cannabis plant material in a liquid vehicle to form a liquid mixture: (ii) contacting the liquid mixture with a first excipient: (iii) contacting the combination comprising the liquid mixture and said first excipient with a form modifying material, for example a coating material, to form a precursor composition; and (iv) treating, for example pelletising, the precursor composition to form the medicinal composition.

Formulations and methods for treating inflammation using pitcher plants are described herein. The pitcher plant is made into herbal preparations, such as tinctures and infused solutions. The herbal preparation of the pitcher plant can be combined with vitamins, minerals, glutathione, solutions, and other plant preparations, such as a hemp plant preparation containing cannabidiol, to make a topical formulation. Administering the formulation to a subject can reduce and treat inflammation.

The present invention generally relates to methods for producing (a) plant extract(s), preferably a Cannabis plant extract. In particular, the present invention relates to a method for producing a Cannabis plant extract comprising delta-9-tetrahydrocannabinol (THC) from a Cannabis plant comprising the following steps: (a) providing a Cannabis plant which comprises delta-9-tetrahydrocannabinol (THC) in a sufficient amount: (b) trimming and drying the flower material separated from the remaining plant material; and (c) treating the flower material of step (b) with a solvent and separating the Cannabis plant extract comprising delta-9-tetrahydrocannabinol (THC) from the flower material. Furthermore, the invention relates to a Cannabis plant extract comprising delta-9-tetrahydrocannabinol (THC) as produced by/obtainable by the methods described herein. Furthermore, the invention relates to the Cannabis plant extract as produced by/obtainable by the herein described methods for use in medicine. Moreover, the present invention relates to the Cannabis plant extract as produced by/obtainable by the herein described methods for use in the treatment and/or prevention of chronic cancer pain, somatic pain, visceral pain, central neuropathic pain, peripheral neuropathic pain and complex pain syndromes.

Provided is a powder tea composition which enables a cannabinoid-containing food and beverages having a high tea leaf flavor and being capable of sufficiently enjoying the effect of cannabinoid to be produced. Provided is a powder tea composition in a powder form, including a cannabinoid-containing water-soluble granulated product and a tea leaf-ground product.

The present invention relates to the process of enrichment of Phytocannabinoids namely CBD and .sup.9-THC from the dried aerial part (leaves and inflorescence) of Cannabis sativa. The present invention also relates to the preparation of formulation having enriched CBD and THC by combining with appropriate acceptable excipients such as nutriose, dextrin and maltodextrin. The present invention also discloses the use of the phytocannabanoids enriched blend for the management of pain including cancer pain & general pain.

Disclosed is the use of hydrolyzed plant-based protein to promote hair growth and reduce hair loss. Hydrolyzed plant-based protein has been found to prolong the active growth phase in hair models, promote gene expression of members of the hair keratin gene family, and increase the release of growth factors.

The present invention relates to the use of cannabidiol (CBD) in the treatment of patients with childhood-onset epilepsy syndromes who are concurrently taking the antiepileptic drug clobazam. When CBD is used in combination with clobazam caution should be taken. The patient may need to be cautioned and/or monitored for side effects of a drug-drug interaction 5 between the two medications. In particular the patient should be cautioned and/or monitored for the occurrence of pneumonia. In such a situation the dose of either the CBD and/or the clobazam may be required to be reduced.

Disclosed herein is a topical composition that delivers advanced environmental protection to the skin, brightens the complexion of the skin, and delivers anti-aging benefits to the skin. The topical composition includes a vitamin C source, a copper source, one or more cannabinoid components, and sodium hyaluronate. Also disclosed herein are methods of administering the topical compositions.

A method and apparatus that allows for the efficient, safe, and odorless extraction of botanical cannabinoids from botanical biomass by utilizing a closed pressing cavity that may optionally include decarboxylation and coextraction features. The closed pressing cavity mitigates parasitic losses of desirable constituents and is a solventless extraction process making it environmentally friendly.